IL125521A - Medicinal preparations for the inhibition of colon cancer - Google Patents

Medicinal preparations for the inhibition of colon cancer

Info

Publication number
IL125521A
IL125521A IL12552197A IL12552197A IL125521A IL 125521 A IL125521 A IL 125521A IL 12552197 A IL12552197 A IL 12552197A IL 12552197 A IL12552197 A IL 12552197A IL 125521 A IL125521 A IL 125521A
Authority
IL
Israel
Prior art keywords
compound
colon cancer
formula
mammal
cells
Prior art date
Application number
IL12552197A
Other languages
English (en)
Hebrew (he)
Other versions
IL125521A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL125521A0 publication Critical patent/IL125521A0/xx
Publication of IL125521A publication Critical patent/IL125521A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
IL12552197A 1996-01-29 1997-01-27 Medicinal preparations for the inhibition of colon cancer IL125521A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (2)

Publication Number Publication Date
IL125521A0 IL125521A0 (en) 1999-03-12
IL125521A true IL125521A (en) 2001-11-25

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12552197A IL125521A (en) 1996-01-29 1997-01-27 Medicinal preparations for the inhibition of colon cancer

Country Status (19)

Country Link
EP (1) EP0921799A4 (ru)
JP (1) JP2000503994A (ru)
KR (1) KR19990082054A (ru)
CN (1) CN1209745A (ru)
AR (1) AR010978A1 (ru)
AU (1) AU707892B2 (ru)
BR (1) BR9700778A (ru)
CO (1) CO4761062A1 (ru)
CZ (1) CZ235498A3 (ru)
EA (1) EA001104B1 (ru)
ID (1) ID15917A (ru)
IL (1) IL125521A (ru)
MX (1) MX9806036A (ru)
NO (1) NO983451D0 (ru)
NZ (1) NZ331105A (ru)
PL (1) PL328147A1 (ru)
TW (1) TW446560B (ru)
WO (1) WO1997026877A1 (ru)
YU (1) YU2397A (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
KR950010891A (ko) * 1993-10-15 1995-05-15 피터 지. 스트링거 내성 종양을 치료하는 방법
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
EA199800677A1 (ru) 1999-02-25
NO983451L (no) 1998-07-27
EA001104B1 (ru) 2000-10-30
KR19990082054A (ko) 1999-11-15
AU707892B2 (en) 1999-07-22
YU2397A (en) 1999-11-22
ID15917A (id) 1997-08-21
CO4761062A1 (es) 1999-04-27
MX9806036A (es) 1998-11-29
IL125521A0 (en) 1999-03-12
CN1209745A (zh) 1999-03-03
PL328147A1 (en) 1999-01-18
EP0921799A4 (en) 2002-03-13
JP2000503994A (ja) 2000-04-04
EP0921799A1 (en) 1999-06-16
AR010978A1 (es) 2000-08-02
CZ235498A3 (cs) 1999-02-17
BR9700778A (pt) 1998-10-06
AU2123997A (en) 1997-08-20
NO983451D0 (no) 1998-07-27
NZ331105A (en) 2000-06-23
TW446560B (en) 2001-07-21
WO1997026877A1 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
NZ250486A (en) Benzothiophene derivatives used to lower serum cholesterol
US5604248A (en) Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
AU698389B2 (en) Methods for inhibiting LDL oxidation and atheroclerosis
PT652000E (pt) Metodos para a inibicao de angiogenese e doencas angiogenicas
AU701701B2 (en) Methods of inhibiting breast disorders
US5451590A (en) Methods of inhibiting sexual precocity
US5843974A (en) Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
AU707892B2 (en) Methods of inhibiting colon tumors
US5843964A (en) Methods of inhibiting endometrial mitoses
US5670523A (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
AU707675B2 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
NZ292017A (en) Use of raloxifene to treat endometrial cancer
CA2244112A1 (en) Methods of inhibiting colon tumors
WO1996026727A1 (en) Methods of inhibiting ovarian cancer
EP0729754A2 (en) 2-Phenyl-3-aroylbonzothiophenes for inhibiting estrogen positive tumors of the brain or CNS
WO1996021441A1 (en) Methods of inhibiting growth hormone effects
CA2244247A1 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force